Information Provided By: 
Fly News Breaks for December 8, 2015
A
Dec 8, 2015 | 06:45 EDT
Goldman analyst Isaac Ro raised the Life Science Tools sector to Attractive from Neutral and upgraded Agilent to Buy and increased his price target to $48 from $38 on shares. Ro said most key end markets are poised to accelerate, offering modest upside to consensus estimates, and Agilent's FY16 guidance looks conservative.
News For A From the Last 2 Days
There are no results for your query A
